Literature DB >> 28089835

Supplementary Tests in Idiopathic Normal Pressure Hydrocephalus: A Single-Center Experience with a Combined Lumbar Infusion Test and Tap Test.

Fabio Raneri1, Maria Angela Samis Zella2, Andrea Di Cristofori3, Barbara Zarino4, Mauro Pluderi4, Diego Spagnoli5.   

Abstract

BACKGROUND: The lumbar infusion test (LIT) and tap test (TT) have previously been described for the diagnosis and selection of appropriate surgical candidates in idiopathic normal pressure hydrocephalus (iNPH).
METHODS: We retrospectively reviewed 81 consecutive patients with a clinical diagnosis of iNPH selected for supplementary testing. Clinical evaluation was scored with the Japanese Grading Scale for Normal Pressure Hydrocephalus, the Global Deterioration Score, and the modified Rankin Scale (mRS). The test protocol included a cerebrospinal fluid pressure monitoring (PMi), an LIT, and a TT. Patients were selected for surgery if outflow resistance was ≥14 mm Hg/mL/minute or if a clinical improvement was recorded after TT.
RESULTS: Sixty-eight patients were selected for ventriculoperitoneal shunting; 72.8% had a positive PMi or LIT, 74.1% had a positive TT, and 63.0% were positive to both tests. Complications were all transient. Clinical evaluation at 12 months after shunting showed a global improvement in 60 patients (88.2%). Overall, 75.0% of patients had no significant disability (mRS score, 1 and 2), 20.6% had an mRS score of 3 or 4, and 4.4% had severe disability after surgery. The positive predictive value of PMi/LIT, TT, or both combined was similar (89.8, 90.0, and 88.2%); however, 21.7% of patients who improved after surgery were selected with either a positive LIT or TT alone.
CONCLUSIONS: LIT and TT are complementary and they can easily be combined in sequence with a low complication rate and high probability of selecting patients with iNPH who may benefit from ventriculoperitoneal shunt surgery.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CSF tap test; Lumbar infusion test; Normal pressure hydrocephalus; VP shunt surgery

Mesh:

Year:  2017        PMID: 28089835     DOI: 10.1016/j.wneu.2017.01.003

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  10 in total

1.  Intraventricular infusion test accuracy in predicting short- and long-term outcome of iNPH patients: a 10-year update of a three-decade experience at a single institution.

Authors:  Gianluca Trevisi; Francesco Signorelli; Chiara de Waure; Vito Stifano; Cosimo Sturdà; Alessandro Rapisarda; Angelo Pompucci; Annunziato Mangiola; Carmelo Anile
Journal:  Neurosurg Rev       Date:  2021-02-15       Impact factor: 3.042

2.  The diagnostic value of the pulsatility curve to predict shunt responsiveness in patients with idiopathic normal pressure hydrocephalus.

Authors:  M W T van Bilsen; L van den Abbeele; V Volovici; H D Boogaarts; R H M A Bartels; E J van Lindert
Journal:  Acta Neurochir (Wien)       Date:  2022-05-30       Impact factor: 2.816

3.  Guidelines for Management of Idiopathic Normal Pressure Hydrocephalus (Third Edition): Endorsed by the Japanese Society of Normal Pressure Hydrocephalus.

Authors:  Madoka Nakajima; Shigeki Yamada; Masakazu Miyajima; Kazunari Ishii; Nagato Kuriyama; Hiroaki Kazui; Hideki Kanemoto; Takashi Suehiro; Kenji Yoshiyama; Masahiro Kameda; Yoshinaga Kajimoto; Mitsuhito Mase; Hisayuki Murai; Daisuke Kita; Teruo Kimura; Naoyuki Samejima; Takahiko Tokuda; Mitsunobu Kaijima; Chihiro Akiba; Kaito Kawamura; Masamichi Atsuchi; Yoshihumi Hirata; Mitsunori Matsumae; Makoto Sasaki; Fumio Yamashita; Shigeki Aoki; Ryusuke Irie; Hiroji Miyake; Takeo Kato; Etsuro Mori; Masatsune Ishikawa; Isao Date; Hajime Arai
Journal:  Neurol Med Chir (Tokyo)       Date:  2021-01-15       Impact factor: 1.742

4.  The Kuopio idiopathic normal pressure hydrocephalus protocol: initial outcome of 175 patients.

Authors:  A Junkkari; A J Luikku; N Danner; H K Jyrkkänen; T Rauramaa; V E Korhonen; A M Koivisto; O Nerg; M Kojoukhova; T J Huttunen; J E Jääskeläinen; V Leinonen
Journal:  Fluids Barriers CNS       Date:  2019-07-25

5.  Usefulness of Brain Positron Emission Tomography with Different Tracers in the Evaluation of Patients with Idiopathic Normal Pressure Hydrocephalous.

Authors:  Maria Vittoria Mattoli; Giorgio Treglia; Maria Lucia Calcagni; Annunziato Mangiola; Carmelo Anile; Gianluca Trevisi
Journal:  Int J Mol Sci       Date:  2020-09-07       Impact factor: 5.923

6.  Evaluating the cerebrospinal fluid tap test with the Hellström iNPH scale for patients with idiopathic normal pressure hydrocephalus.

Authors:  Johanna Rydja; Andreas Eleftheriou; Fredrik Lundin
Journal:  Fluids Barriers CNS       Date:  2021-04-07

Review 7.  The Pathogenesis Based on the Glymphatic System, Diagnosis, and Treatment of Idiopathic Normal Pressure Hydrocephalus.

Authors:  Changwu Tan; Xiaoqiang Wang; Yuchang Wang; Chuansen Wang; Zhi Tang; Zhiping Zhang; Jingping Liu; Gelei Xiao
Journal:  Clin Interv Aging       Date:  2021-01-15       Impact factor: 4.458

8.  The Value of the Correlation Coefficient Between the ICP Wave Amplitude and the Mean ICP Level (RAP) Combined With the Resistance to CSF Outflow (Rout) for Early Prediction of the Outcome Before Shunting in Posttraumatic Hydrocephalus.

Authors:  Chao Zhang; Si-Yu Long; Wen-Dong You; Xu-Xu Xu; Guo-Yi Gao; Xiao-Feng Yang
Journal:  Front Neurol       Date:  2022-04-26       Impact factor: 4.086

Review 9.  The pathogenesis of idiopathic normal pressure hydrocephalus based on the understanding of AQP1 and AQP4.

Authors:  Zitong Zhao; Jian He; Yibing Chen; Yuchang Wang; Chuansen Wang; Changwu Tan; Junbo Liao; Gelei Xiao
Journal:  Front Mol Neurosci       Date:  2022-09-20       Impact factor: 6.261

10.  Preoperative evaluation using external lumbar drainage for patients with posthemorrhagic hydrocephalus: A prospective, monocentric, randomized controlled trial.

Authors:  Tong Sun; Junwen Guan; Jingguo Yang; Yikai Yuan; Yicheng Zhou; Chao You
Journal:  Medicine (Baltimore)       Date:  2020-08-28       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.